Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • News
    • pharma-news

    pharma-news - Page 80

    Sanofi opens digital biologics manufacturing facility in US

    Sanofi opens digital biologics manufacturing facility in US

    Farhat Nasim16 Oct 2019 9:45 AM IST
    The facility in Framingham accelerates the recent transformation of Sanofi's Industrial Affairs organization to focus on biologics-based therapies, in...
    Abbott, Tandem Diabetes Care explore integrated solutions to improve diabetes management

    Abbott, Tandem Diabetes Care explore integrated solutions to improve diabetes management

    Farhat Nasim16 Oct 2019 9:40 AM IST
    New Delhi: Abbott and Tandem Diabetes Care recently announced that they intend to develop and commercialize integrated diabetes solutions that combine...
    Judge admits making USD 107 million miscalculation in Johnson and Johnson opioid case

    Judge admits making USD 107 million miscalculation in Johnson and Johnson opioid case

    Farhat Nasim16 Oct 2019 9:00 AM IST
    New Delhi: An Oklahoma judge on Tuesday acknowledged making a nearly $107 million miscalculation in determining how much drug maker Johnson &...
    Granules India to exit from Chinese JV Granules Biocause

    Granules India to exit from Chinese JV Granules Biocause

    Medical Dialogues Bureau15 Oct 2019 3:07 PM IST
    Granules India formed the Chinese joint venture, Granules Biocause Pharmaceuticals in 2007 to ensure a regular supply of ibuprofen API to support its...
    AstraZeneca, Pfizer, Takeda Pharma ink agreement with ImaginAb to develop tumour imaging technology

    AstraZeneca, Pfizer, Takeda Pharma ink agreement with ImaginAb to develop tumour imaging technology

    Farhat Nasim15 Oct 2019 9:45 AM IST
    New Delhi: ImaginAb, Inc., a clinical-stage immuno-oncology imaging company, recently announced the signing of a multi-party collaboration agreement...
    Allergan shareholders okays USD 63 billion AbbVie acquisition

    Allergan shareholders okays USD 63 billion AbbVie acquisition

    Medical Dialogues Bureau15 Oct 2019 9:30 AM IST
    Under the terms of the agreement announced on June 25, 2019, AbbVie will acquire Allergan in a cash and stock transaction for a transaction equity...
    Roche Rituximab shows positive data in rare skin disease Pemphigus Vulgaris

    Roche Rituximab shows positive data in rare skin disease Pemphigus Vulgaris

    Medical Dialogues Bureau15 Oct 2019 9:00 AM IST
    New Delhi: Roche recently announced data from the Phase III PEMPHIX study evaluating the efficacy and safety of MabThera/Rituxan (rituximab) compared...
    Morepen Labs adds blockbuster Rivaroxaban, Vildagliptin, UDCA to API portfolio

    Morepen Labs adds blockbuster Rivaroxaban, Vildagliptin, UDCA to API portfolio

    Farhat Nasim14 Oct 2019 1:36 PM IST
    While two products Rivaroxaban and Vildagliptin will augment Morepen Lab's presence in the cardiac and diabetic segments respectively, the third...
    FIRST: Sun Pharma unveils dry-eye treatment drug CEQUA in US

    FIRST: Sun Pharma unveils dry-eye treatment drug CEQUA in US

    Farhat Nasim14 Oct 2019 1:13 PM IST
    New Delhi: Through a release, drug major, Sun Pharmaceutical Industries Ltd. (Sun Pharma) today announced that one of its wholly-owned subsidiaries...
    Torrent Pharma recalls bottles of Losartan over CGMP deviations

    Torrent Pharma recalls bottles of Losartan over CGMP deviations

    Medical Dialogues Bureau14 Oct 2019 9:30 AM IST
    As per USFDA report, Torrent Pharma is also recalling 39,432 bottles of Losartan Potassium Tablets, USP in the strength of 100 mg from the US and...
    JnJ Ebola vaccine to arrive in Congo in November: Health Authorities

    JnJ Ebola vaccine to arrive in Congo in November: Health Authorities

    Farhat Nasim14 Oct 2019 9:00 AM IST
    The JnJ vaccine will complement another vaccine manufactured by Merck, which has been administered to more than 225,000 people. It requires two...
    CDSCO adds another port for enhancing import of drugs

    CDSCO adds another port for enhancing import of drugs

    Farhat Nasim13 Oct 2019 3:37 PM IST
    New Delhi: Through a recent Gazette notification, the apex drug regulatory body Central Drugs Standard Control Organization (CDSCO) has apprised about...
    PrevNext

    Popular Stories

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes feedback

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes...

    Owner of BLK Hospital, Radiant Life care looks to buy Max Healthcare stake

    Owner of BLK Hospital, Radiant Life care looks to buy Max Healthcare stake

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop production

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop...

    French court dismisses damage claims against Merck over Levothyrox

    French court dismisses damage claims against Merck over Levothyrox

    Novartis Expiry of Patent for Blockbuster Vildagliptin to Clear Way for Competitors

    Novartis Expiry of Patent for Blockbuster Vildagliptin to Clear Way for Competitors

    Illegal steroid smuggling ring allegedly led by India-based Alpha Pharma busted in UK

    Illegal steroid smuggling ring allegedly led by India-based Alpha Pharma busted in UK

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok